Page last updated: 2024-09-05

erlotinib hydrochloride and Pruritus

erlotinib hydrochloride has been researched along with Pruritus in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (33.33)	29.6817
2010's	8 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ayanoglu, BT; Demirdag, HG; Yalici-Armagan, B	1
Kishi, A; Kiyohara, Y; Yamazaki, N	1
Del Giudice, P; Delord, JP; Hubiche, T; Roché, H; Sibaud, V; Tournier, E	1
Chen, KL; Cho, YT; Chu, CY; Lin, CC; Sheen, YS; Tsai, HE; Yang, CW	1
Santini, D; Tonini, G; Vincenzi, B	1
Levêque, D	1
Buhren, BA; Gerber, PA; Homey, B	1
Blanchet, B; Goldwasser, F; Mir, O	1
Calarese, P; Morse, L	1
Gerdes, S; Mrowietz, U	1
Kardaun, SH; van Duinen, KF	1
Loffeld, A; Orpin, SD; Talsania, N	1

Reviews

2 review(s) available for erlotinib hydrochloride and Pruritus

Article	Year
Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer. Journal of the American Academy of Dermatology, 2013, Volume: 69, Issue:3 Topics: Acneiform Eruptions; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Eruptions; Erlotinib Hydrochloride; Humans; Ichthyosis; Lung Neoplasms; Paronychia; Patient Education as Topic; Pruritus; Quinazolines	2013
EGFR-targeted therapy and related skin toxicity. Seminars in oncology nursing, 2006, Volume: 22, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Evidence-Based Medicine; Female; Humans; Ichthyosis; Middle Aged; Neoplasms; Nurse's Role; Oncology Nursing; Practice Guidelines as Topic; Protein Kinase Inhibitors; Pruritus; Quinazolines; Signal Transduction; Skin Care; Trastuzumab	2006

Article

Year

Journal of the American Academy of Dermatology, 2013, Volume: 69, Issue:3

Topics: Acneiform Eruptions; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Eruptions; Erlotinib Hydrochloride; Humans; Ichthyosis; Lung Neoplasms; Paronychia; Patient Education as Topic; Pruritus; Quinazolines

2013

EGFR-targeted therapy and related skin toxicity.

Seminars in oncology nursing, 2006, Volume: 22, Issue:3

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Evidence-Based Medicine; Female; Humans; Ichthyosis; Middle Aged; Neoplasms; Nurse's Role; Oncology Nursing; Practice Guidelines as Topic; Protein Kinase Inhibitors; Pruritus; Quinazolines; Signal Transduction; Skin Care; Trastuzumab

2006

Other Studies

10 other study(ies) available for erlotinib hydrochloride and Pruritus

Article	Year
Targeted tumour therapy induced papulopustular rash and other dermatologic side effects: a retrospective study. Cutaneous and ocular toxicology, 2019, Volume: 38, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Female; Humans; Lapatinib; Male; Middle Aged; Molecular Targeted Therapy; Panitumumab; Pruritus; Retrospective Studies	2019
Late epidermal growth factor receptor inhibitor-related papulopustular rash: a distinct clinical entity. Clinical and experimental dermatology, 2016, Volume: 41, Issue:1 Topics: Adult; Aged; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Male; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pruritus; Quinazolines; Skin Diseases, Papulosquamous; Staphylococcal Infections; Staphylococcus aureus	2016
Comparison of Skin Toxic Effects Associated With Gefitinib, Erlotinib, or Afatinib Treatment for Non-Small Cell Lung Cancer. JAMA dermatology, 2016, Volume: 152, Issue:3 Topics: Acneiform Eruptions; Afatinib; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Compassionate Use Trials; Cross-Sectional Studies; Drug Eruptions; Erlotinib Hydrochloride; Gefitinib; Humans; Ichthyosis; Lung Neoplasms; Paronychia; Pruritus; Quinazolines; Retrospective Studies	2016
Aprepitant for erlotinib-induced pruritus. The New England journal of medicine, 2010, Jul-22, Volume: 363, Issue:4 Topics: Adult; Aged; Aprepitant; Erlotinib Hydrochloride; Female; Humans; Male; Morpholines; Neurokinin-1 Receptor Antagonists; Protein Kinase Inhibitors; Pruritus; Quinazolines	2010
Aprepitant for erlotinib-induced pruritus. The New England journal of medicine, 2010, 10-21, Volume: 363, Issue:17 Topics: Antineoplastic Agents; Aprepitant; Area Under Curve; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Interactions; Erlotinib Hydrochloride; Humans; Morpholines; Neurokinin-1 Receptor Antagonists; Off-Label Use; Protein Kinase Inhibitors; Pruritus; Quinazolines	2010
More on aprepitant for erlotinib-induced pruritus. The New England journal of medicine, 2011, 02-03, Volume: 364, Issue:5 Topics: Antiemetics; Aprepitant; Erlotinib Hydrochloride; Humans; Morpholines; Neurokinin-1 Receptor Antagonists; Off-Label Use; Protein Kinase Inhibitors; Pruritus; Quinazolines; Substance P	2011
More on aprepitant for erlotinib-induced pruritus. The New England journal of medicine, 2011, 02-03, Volume: 364, Issue:5 Topics: Adenocarcinoma; Aprepitant; Drug Interactions; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Middle Aged; Morpholines; Neurokinin-1 Receptor Antagonists; Off-Label Use; Protein Kinase Inhibitors; Pruritus; Quinazolines	2011
Follicular rash during therapy with erlotinib (Tarceva). Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2006, Volume: 4, Issue:10 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Facial Dermatoses; Folliculitis; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Pruritus; Quinazolines; Treatment Outcome	2006
Erlotinib-induced florid acneiform rash complicated by extensive impetiginization. Clinical and experimental dermatology, 2008, Volume: 33, Issue:1 Topics: Aged; Anti-Bacterial Agents; Diarrhea; Dose-Response Relationship, Drug; Drug Eruptions; Emollients; Erlotinib Hydrochloride; Humans; Male; Middle Aged; Minocycline; Protein Kinase Inhibitors; Pruritus; Quinazolines	2008
Colloidal oatmeal lotion is an effective treatment for pruritus caused by erlotinib. Clinical and experimental dermatology, 2008, Volume: 33, Issue:1 Topics: Avena; Colloids; Erlotinib Hydrochloride; Humans; Male; Middle Aged; Phytotherapy; Plant Preparations; Protein Kinase Inhibitors; Pruritus; Quinazolines	2008